AHPA Alerts

On January 28, 2019, AHPA submitted comments to the Food and Drug Administration (FDA) urging the agency to ensure that any rule or guidance that the agency may adopt on the use of dairy names (e.g., “milk,” “cream,” “butter,” etc.) on the labels of plant-based products expressly does not apply to any such product that is not generally used as a substitute for or marketed to resemble a dairy product.

Industry professionals are eligible to attend the event, specifically practicing health professionals with at least a master’s degree from a recognized academic program who works in either a healthcare, educational, or industrial setting or is self-employed.

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Join a renowned faculty of herbalists for a hands-on, guided tour of the Fullerton Arboretum's 26-acre botanical garden, featuring more than 4,000 plant species from around the globe.

The U.S. Department of Agriculture (USDA) Agricultural Marketing Service (AMS) issued a final rule on December 20 that establishes the new national mandatory bioengineered (BE) food disclosure standard. The final rule does not incorporate significant revisions recommended by AHPA and consumer groups that were aimed at ensuring U.S. consumers can discern if their food includes genetically modified organisms (GMOs) or ingredients derived from GMOs.

The American Herbal Products Association (AHPA) published slack-fill guidance in 2016 and revised the document in 2019 to help the regulated supplement industry inform consumers and comply with all relevant federal requirements.

Two-part webinar will provide data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.

A proposal that would have drastically limited access to safe, legal and popular products for Arizonans was changed recently thanks to the Natural Products Association (NPA) and the American Herbal Products Association (AHPA), who worked with the Arizona Board of Pharmacy and other state policymakers on the issue.

AHPA President Michael McGuffin on Friday provided an overview of federal legal issues for hemp and hemp-derived products at the World of Hemp Forum held at the annual SOHO Expo in Orlando, FL.

Nationally board-certified acupuncturist and Chinese herbalist at the Cleveland Clinic Galina Roofener shared safety data and lessons learned from the Cleveland Clinic Wellness Institute’s Traditional Chinese Herbal Medicine (TCHM) Program at her keynote delivered at the American Herbal Products Association’s (AHPA’s) 7th Annual Botanical Congress presented on Nov. 10 in Las Vegas at the SupplySide West trade show.